A very important aspect of every 501(c)(3) nonprofit organization is its transparency into where its funds actually go.
The short answer to that question is easy—our beneficiary organizations, which in 2020 includes nine nonprofits:
In past years has been the Leukemia & Lymphoma Society, St. Baldrick’s Foundation, and the Pancreatic Cancer Action Network.
How Our Beneficiary Gifts are Creating Change
2018 – 2019
Alex’s Lemonade Stand Foundation
$1,365,000 donated through 2019
If you don’t know who Alex Scott was, you should. Since before her first birthday Alex bravely fought cancer for years, all while raising money at her lemonade stand to help other children fight cancer too. Her spirit inspired many others to set up their own lemonade stands, and before her passing she raised over $1,000,000. Her parents, Liz and Jay Scott, committed to continuing her inspiring legacy through Alex’s Lemonade Stand Foundation.
Thanks to our gifts in 2018 and 2019, we have funded grants at the following institutions:
- $100k – University of Texas Southwestern Medical Center
- $75k – Children’s Hospital of Philadelphia
- $75k – Stanford University School of Medicine
- $75k – University of Miami
- $50k – Connecticut Children’s Medical Center
- $50k – Johns Hopkins University School of Medicine
- $50k – Duke University
- $50k – Emory University
- $50k – University of Florida
- $50k – University of Texas Health Science Center at San Antonio
- $50k – Children’s Hospital of Chicago
- $50k – Nationwide Children’s Hospital
- $50k – St. Jude Children’s Research Hospital
- $50k – University of Massachusetts Medical School
- $50k – Baylor College of Medicine
- $25k – Harvard University
- $25k – Northwestern University
- $25k – Yale School of Medicine
- $25k – New York University School of Medicine
- $25k – University of North Carolina
- $25k – Washington University (St. Louis)
2016 – 2017
Pancreatic Cancer Action Network
Our partnership with the Pancreatic Cancer Action Network started with a simple idea—with a 5-year survival rate under 10% and the third leading cause of cancer-related deaths in the US, pancreatic cancer is “one of the biggest, baddest dudes in the room.” But as BJJ practitioners, who better to fight?
In early 2016 we committed to help the Pancreatic Cancer Action Network make significant strides in early detection, treatment, and improving clinical trial opportunities for patients.
2014 – 2015
St. Baldrick’s Foundation
As a partner of St. Baldrick’s, we had the opportunity to jointly fund four pediatric cancer research grants. The researchers included Dr. Colleen Annesley of Johns Hopkins Hospital in Baltimore, MD, Dr. Jennifer Wu of Boston’s Children’s Hospital in Boston, MA, Dr. Juan Vasquez (as seen in the above video) of Yale University School of Medicine in New Haven, CT, and Dr. Sun Choo of UCSD in San Diego, CA. You can read more about Dr. Annesley and Dr. Wu’s research in our 2014 Annual Report and more about Dr. Choo and Dr. Vasquez’s research in our 2015 Annual Report. We even had the honor of welcoming Dr. Wu at our 2014 Massachusetts BJJ Open and Dr. Choo at our 2016 San Diego BJJ Open to speak to our competitors and volunteers about how their research is helping improve cancer survivorship.
2012 – 2013
Leukemia & Lymphoma Foundation
We were honored to work with the Leukemia & Lymphoma Society as our inaugural beneficiary organization. Our donations to both the Connecticut and Massachusetts LLS chapters benefited localized patient support and education. It was important to us to work with the local chapters since our 2012 and 2013 fundraising tournaments took place in Stratford, CT, and Danvers, MA.
“The generous donations given by all of the participants and supporters of Tap Cancer Out enable The Leukemia & Lymphoma Society to provide patients and their families with much needed support as well as funding life saving research,” said Brandy Sinisi, Campaign Manager for the Leukemia & Lymphoma Society Connecticut Chapter. “Thank you to the entire Tap Cancer Out team and their supporters for their hard work and determination to put an end not just to blood cancers, but to all cancers.”